Luca Maini named an Affiliate Fellow of the Stigler Center at Chicago Booth, supporting his research on competition and regulation in pharmaceutical markets.
Professor Alex Luedtke has been named the 2026 recipient of the Mortimer Spiegelman Award, one of the most prestigious honors for early-career statisticians in public health and biostatistics.
Professor Michael E. Chernew has received the 2026 William B. Graham Prize, the highest distinction in health services research, for his work on healthcare spending and its impact on care delivery and costs.
Award recognizes early-career statistical scientists who demonstrate strong leadership and significant potential to advance and shape the future of the field.
Joseph P. Newhouse, Research Professor and John D. MacArthur Professor of Health Policy and Management (Emeritus), recognized by the American Economic Association as a 2025 Distinguished Fellow for his pioneering contributions to health economics—from leading the landmark RAND Health Insurance Experiment to founding the Journal of Health Economics and shaping health policy through decades of influential research and mentorship.
Two PCORI-backed efforts will open the “black box” of treatment AI and knit together trial and real-world evidence—turning fragmented findings into clear, personalized guidance for patients and clinicians.
Health Care Policy congratulates Nicole Maestas on her election to the National Academy of Medicine, recognizing her pioneering work on the economics of disability, aging, and health insurance, and her national leadership in building the evidence base for disability policymaking.
Congratulations to Dr. Fangli Geng, recipient of the 2025 AcademyHealth Outstanding Dissertation Award, for her pioneering research on optimizing post-acute care for older adults.
Michael Chernew recognized for his outstanding leadership and impact on health services research and policy with Reinhardt Distinguished Career Award (AcademyHealth 2025)
An editorial by J. Michael McWilliams warns that flaws in Medicare Advantage’s payment model are allowing insurers to game diagnosis coding for financial gain—costing taxpayers billions and undermining fair competition.
